Woods Keith insider trades
Woods Keith has filed 19 Form 4s with the SEC that we hold, for Scholar Rock Holding Corp (SRRK) (Chief Operating Officer), Neurogene Inc. (NGNE) (Director), TScan Therapeutics, Inc. (TCRX) (Director) and X4 Pharmaceuticals, Inc (XFOR) (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 2 sales worth $1.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($1.2M). The largest single trade was a sale of 16,746 shares of Scholar Rock Holding Corp worth $715.1K, dated 2026-01-13. The first filing on our record is dated 2023-10-18 and the latest 2026-09-25.
Scholar Rock Holding Corp (SRRK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-01-13 | S, sale reported on Form 4 | 16,746 | $715.1K | 2026-01-15 |
| 2026-04-16 | S, sale reported on Form 4 | 10,220 | $506.6K | 2026-04-20 |
Neurogene Inc. (NGNE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TScan Therapeutics, Inc. (TCRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
X4 Pharmaceuticals, Inc (XFOR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rocket Pharmaceuticals, INC. (RCKT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1996804) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms